APA (7th ed.) Citation

Xu, N., Fang, P., Zhou, L., Han, X., Jiang, Y., Wang, X., . . . Zhang, D. (2025). SLAMF7 promotes TCRαβ+ double negative T cell antitumor activity through enhancing glutamine metabolism. Journal of Experimental & Clinical Cancer Research (17569966), 44(1), 1. https://doi.org/10.1186/s13046-025-03570-w

Chicago Style (17th ed.) Citation

Xu, Nan, et al. "SLAMF7 Promotes TCRαβ+ Double Negative T Cell Antitumor Activity Through Enhancing Glutamine Metabolism." Journal of Experimental & Clinical Cancer Research (17569966) 44, no. 1 (2025): 1. https://doi.org/10.1186/s13046-025-03570-w.

MLA (9th ed.) Citation

Xu, Nan, et al. "SLAMF7 Promotes TCRαβ+ Double Negative T Cell Antitumor Activity Through Enhancing Glutamine Metabolism." Journal of Experimental & Clinical Cancer Research (17569966), vol. 44, no. 1, 2025, p. 1, https://doi.org/10.1186/s13046-025-03570-w.